Health Technology Assessment
The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis
-
Type:Extended Research Article Our publication formats
-
Journal:
-
Issue:Volume: 8, Issue: 11
-
Published:
-
Citation:Barton P, Jobanputra P, Wilson J, Bryan S, Burls A. The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technol Assess 2004;8(11). https://doi.org/10.3310/hta8110
-
DOI: